ArticlePloS one2024

Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis.

Umesh Kathad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.